Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

NCT04536077 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04536077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
August 13, 2021
Completion date
November 21, 2023
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the pancreas, pancreas cancer, pancreatic cancer